Enallylpropymal
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
Synonyms | Enallylpropymal |
CAS Number | 1861-21-8 Y |
PubChem (CID) | 95636 |
ChemSpider | 86329 |
ECHA InfoCard | 100.015.876 |
Chemical and physical data | |
Formula | C11H16N2O3 |
Molar mass | 224.256 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
| |
| |
(verify) |
Enallylpropymal (Narconumal) is a barbiturate derivative developed by Hoffman la Roche in the 1930s.[1] It has sedative and hypnotic effects and is considered to have a moderate abuse potential.[2]
References
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.